Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Norwegian (OSEAX) Healthcare Sector Analysis

UpdatedMay 31, 2026
DataAggregated Company Financials
Companies21
  • 7D-0.7%
  • 3M3.8%
  • 1Y-5.7%
  • YTD-10.0%

Last week, the Healthcare industry hasn't moved much but INIFY Laboratories is up 37% in that time. Unfortunately though, the industry is down 5.7% over the past 12 months. Earnings are forecast to grow by 24% annually.

Sector Valuation and Performance

Has the Norwegian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 31 May 2026NOK 17.3bNOK 3.9b-NOK 631,066,996.1923.1x-27.4x4.4x
Tue, 28 Apr 2026NOK 17.3bNOK 3.7b-NOK 504,596,341.6639x-34.3x4.7x
Thu, 26 Mar 2026NOK 16.3bNOK 3.7b-NOK 566,268,706.3834.3x-28.9x4.4x
Sat, 21 Feb 2026NOK 16.7bNOK 3.7b-NOK 622,242,318.0239.2x-26.8x4.5x
Mon, 19 Jan 2026NOK 18.0bNOK 3.7b-NOK 608,808,823.8230.6x-29.6x4.8x
Wed, 17 Dec 2025NOK 17.4bNOK 3.7b-NOK 612,489,026.2731.6x-28.4x4.7x
Fri, 14 Nov 2025NOK 17.0bNOK 3.7b-NOK 630,061,355.2931.8x-27x4.6x
Sun, 12 Oct 2025NOK 17.1bNOK 3.6b-NOK 718,209,106.5426.3x-23.8x4.7x
Tue, 09 Sep 2025NOK 17.5bNOK 3.6b-NOK 695,927,688.2027.2x-25.2x4.8x
Thu, 07 Aug 2025NOK 17.4bNOK 3.9b-NOK 1,051,733,817.6023.2x-16.6x4.5x
Sat, 05 Jul 2025NOK 17.4bNOK 3.9b-NOK 1,034,548,580.1826.3x-16.8x4.5x
Mon, 02 Jun 2025NOK 16.5bNOK 3.9b-NOK 1,134,479,658.9227.3x-14.6x4.2x
Wed, 30 Apr 2025NOK 16.0bNOK 3.5b-NOK 1,199,497,135.5717.4x-13.3x4.6x
Fri, 28 Mar 2025NOK 16.5bNOK 3.4b-NOK 1,292,131,140.5917.6x-12.7x4.8x
Sun, 23 Feb 2025NOK 16.9bNOK 3.8b-NOK 1,135,818,732.2023.7x-14.9x4.5x
Tue, 21 Jan 2025NOK 16.1bNOK 3.8b-NOK 1,105,466,950.5624x-14.5x4.3x
Thu, 19 Dec 2024NOK 16.0bNOK 3.8b-NOK 1,102,888,487.2326.5x-14.5x4.3x
Sat, 16 Nov 2024NOK 15.4bNOK 4.0b-NOK 977,723,226.4321.3x-15.8x3.8x
Mon, 14 Oct 2024NOK 17.5bNOK 4.0b-NOK 916,910,115.9620x-19.1x4.4x
Wed, 11 Sep 2024NOK 18.6bNOK 4.1b-NOK 913,648,175.7117.7x-20.3x4.6x
Fri, 09 Aug 2024NOK 20.8bNOK 4.0b-NOK 967,309,537.7717x-21.5x5.2x
Sun, 07 Jul 2024NOK 21.5bNOK 4.0b-NOK 1,005,580,535.3717.2x-21.4x5.4x
Tue, 04 Jun 2024NOK 23.1bNOK 4.2b-NOK 1,125,418,751.6017.7x-20.5x5.5x
Thu, 02 May 2024NOK 21.9bNOK 4.2b-NOK 1,141,117,324.2625.5x-19.2x5.2x
Sat, 30 Mar 2024NOK 21.8bNOK 4.2b-NOK 1,120,111,404.1727.2x-19.5x5.2x
Mon, 26 Feb 2024NOK 27.6bNOK 4.2b-NOK 1,210,337,447.2027.1x-22.8x6.6x
Wed, 24 Jan 2024NOK 30.3bNOK 4.1b-NOK 1,590,739,642.0023.3x-19.1x7.4x
Fri, 22 Dec 2023NOK 29.2bNOK 4.1b-NOK 1,580,755,601.0023.2x-18.5x7.1x
Sun, 19 Nov 2023NOK 28.0bNOK 4.1b-NOK 1,587,401,920.0021.9x-17.6x6.8x
Tue, 17 Oct 2023NOK 27.3bNOK 3.6b-NOK 1,807,028,621.0033.6x-15.1x7.7x
Thu, 14 Sep 2023NOK 27.2bNOK 3.6b-NOK 1,809,882,265.0032.6x-15x7.7x
Sat, 12 Aug 2023NOK 29.1bNOK 3.4b-NOK 1,811,562,305.0029.2x-16.1x8.5x
Mon, 10 Jul 2023NOK 28.6bNOK 3.4b-NOK 1,792,449,759.0042.4x-15.9x8.4x
Wed, 07 Jun 2023NOK 30.0bNOK 3.4b-NOK 1,868,401,280.0041.4x-16.1x8.9x
Price to Earnings Ratio

-16.1x


Total Market Cap: NOK 30.0bTotal Earnings: -NOK 1,868,401,280.00Total Revenue: NOK 3.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Healthcare Sector Price to Earnings3Y Average -20.1x202420252026
Current Industry PE
  • Investors are pessimistic on the Norwegian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.5x is higher than the industry's current PS ratio of 4.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have improved over the last three years.
  • Revenues for these companies have grown 4.7% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare sector?

NO Market-2.32%
Healthcare-0.75%
Healthcare Services37.02%
Medical Equipment1.22%
Biotech0.39%
Pharma-4.09%
Healthtech-7.78%
Industry PE
    Forecasted Growth
    • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 71% over the next 5 years.
    • This is better than its past earnings decline of 64% per year.
    • In contrast, the Pharma industry is expected to see its earnings grow by 6.5% per year over the next few years.

    Top Stock Gainers and Losers

    Which companies have driven the market over the last 7 days?

    CompanyLast Price7D1YValuation
    		INIFY INIFY LaboratoriesNOK 4.9637.0%
    +NOK 144.0m    		-24.3%n/a
    		AZT ArcticZymes TechnologiesNOK 22.5012.5%
    +NOK 127.7m    		42.0%PE85.5x
    		MEDI MedistimNOK 228.001.8%
    +NOK 73.2m    		15.4%PE26.7x
    		TRMED Thor MedicalNOK 4.642.5%
    +NOK 41.6m    		95.8%PS1998.6x
    		OMDA OmdaNOK 35.302.6%
    +NOK 18.5m    		-33.1%PS1.5x

    Latest News

    LYTIX
    NOK 10.55
    Lytix Biopharma
    7D
    -4.5%
    1Y
    26.5%
    New Narrative • May 25

    Neoadjuvant Melanoma And Basal Cell Catalysts Will Reshape Long Term Prospects

    Catalysts About Lytix Biopharma Lytix Biopharma develops oncolytic molecules such as ruxotemitide and LTX-401 that are designed to destroy tumor cells and activate the immune system in cancer treatment. What are the underlying business or industry changes driving this perspective?
    MEDI
    NOK 228.00
    Medistim
    7D
    1.8%
    1Y
    15.4%
    Narrative Update • May 25

    MEDI: Clinical Trial Momentum And Dividend Visibility Will Support Future Performance

    Analysts have kept Medistim's fair value estimate steady at NOK 315.0. This reflects slightly updated assumptions on discount rate, revenue growth, profit margin and future P/E, without a change in their overall price target stance. What's in the News Medistim ASA plans a board meeting on February 26, 2026, to consider and resolve the annual general meeting and an ordinary dividend for 2025 (company announcement).
    NORDH
    NOK 27.40
    Nordhealth
    7D
    -8.7%
    1Y
    -27.9%
    NAVA
    NOK 17.65
    Navamedic
    7D
    -2.5%
    1Y
    -19.8%
    OMDA
    NOK 35.30
    Omda
    7D
    2.6%
    1Y
    -33.1%
    Analysis Article • May 23

    Omda AS (OB:OMDA) Just Reported, And Analysts Assigned A kr50.00 Price Target

    Last week, you might have seen that Omda AS ( OB:OMDA ) released its quarterly result to the market. The early response...
    PHO
    NOK 62.00
    Photocure
    7D
    -6.2%
    1Y
    23.5%
    NYKD
    NOK 3.14
    Nykode Therapeutics
    7D
    -4.4%
    1Y
    75.4%
    New Narrative • May 19

    Head And Neck Cancer Trial Progress And Cash Runway Will Support Long Term Potential

    Catalysts About Nykode Therapeutics Nykode Therapeutics is a biotechnology company focused on developing immunotherapies for cancer and autoimmune diseases. What are the underlying business or industry changes driving this perspective?
    AZT
    NOK 22.50
    ArcticZymes Technologies
    7D
    12.5%
    1Y
    42.0%
    ABS
    NOK 3.30
    Arctic Bioscience
    7D
    0.6%
    1Y
    -2.9%
    CODE
    NOK 2.80
    CodeLab Capital
    7D
    5.7%
    1Y
    -3.1%
    EXTX
    NOK 0.87
    EXACT Therapeutics
    7D
    -40.8%
    1Y
    -68.9%
    TRMED
    NOK 4.64
    Thor Medical
    7D
    2.5%
    1Y
    95.8%
    INIFY
    NOK 4.96
    INIFY Laboratories
    7D
    37.0%
    1Y
    -24.3%
    SOFTX
    NOK 0.11
    SoftOx Solutions
    7D
    -6.6%
    1Y
    36.8%
    Analysis Article • Mar 28

    We Think SoftOx Solutions (OB:SOFTX) Needs To Drive Business Growth Carefully

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
    ZLNA
    NOK 21.70
    Zelluna
    7D
    -4.0%
    1Y
    70.3%